Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 9465 - 9472 of 11454 results
Ebola Exclusions from Commercial Insurance Policies
October 29, 2014| Blog| Viewpoint
ML Strategies Posts Weekly Health Care Update on October 27, 2014
October 28, 2014| Blog| Viewpoint
NYS Department of Health Proposes Changes to Certificate of Need Process
October 28, 2014| Blog| Viewpoint
Do You Really Own Your Employee's Knowledge
October 28, 2014| Blog| Viewpoint
NEWIEE to Host Annual Meeting and Autumn Extravaganza on November 6
October 27, 2014| Blog| Viewpoint
SHRM: Big Data Only as Good as Data In
October 26, 2014| Blog| Viewpoint
Another One Bites the Dust - Court Strikes Down Non-solicitation Agreement as Overbroad under New York Law
October 24, 2014| Blog| Viewpoint
News & Press Releases
Venture Mega-Rounds Return to Biotech
September 26, 2024
Member Cheryl Reicin was quoted in WSJ Pro Venture Capital in an article about how venture mega rounds are becoming more frequent in the biotech industry. Specifically, Cheryl discusses the need for startups to be aware of the pressures and implications that may come from larger funding rounds.
Lenovo’s Setback in Ericsson ITC Case May Impact Other SEP Disputes
September 26, 2024
Intellectual Property Division Chair Michael Renaud was quoted by IAM in an article about the ITC case between Ericsson and Lenovo and its potential implications for FRAND negotiations. While most ITC cases involving Standard Essential Patents (SEPs) have resulted in no violation findings, this case could change that.
Mintz Ranked in 2025 Edition of Chambers Canada
September 26, 2024
Mintz announced that it has been ranked in the 2025 edition of Chambers Canada. The firm was rankedin both the Life Sciences and Cannabis Law categories. Six attorneys were also ranked in individual categories including Life Sciences, Private Equity, Investment Funds, Cannabis, and Pensions & Benefits.